Cumulative steroid doses and response rates to immune checkpoint inhibitors in metastatic cancer.

e15133Background: Steroids are the mainstay of immune-related adverse effect (irAE) management, as well as for other indications in cancer treatment. Previous studies evaluating whether steroids ha...